News


Warning: file_get_contents(http://graph.facebook.com/?ids=http://globalpharmaupdate.com/treatment-of-multiple-myeloma-to-be-looked-into-by-pharmamar-and-aplidin/): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/globalph/public_html/wp-content/themes/delhiitsolutionsdotcom/inc/tn-counter-post.php on line 26

Warning: file_get_contents(http://graph.facebook.com/?ids=http://globalpharmaupdate.com/als-phase-2-study-with-flx-787-launched-by-flex-pharma-in-us/): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/globalph/public_html/wp-content/themes/delhiitsolutionsdotcom/inc/tn-counter-post.php on line 26

Warning: file_get_contents(http://graph.facebook.com/?ids=http://globalpharmaupdate.com/obesity-drug-helps-up-to-13-8-percent-weight-loss-in-phase-2-trial/): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/globalph/public_html/wp-content/themes/delhiitsolutionsdotcom/inc/tn-counter-post.php on line 26
share

HitGen Ltd announced that the company has entered into a multi-target multi-year collaboration with LEO Pharma A/S ,...

share

Soin Neuroscience, a biotech startup based in Dayton, OH, has recently signed a drug development deal with Cleveland...

share

Omeros Corporation announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment...

share

PharmaMar announced the start of a multicenter quadruple combination clinical study with Aplidin (plitidepsina), along with other compounds...

share

AbbVie Inc said on Friday it had received European approval to market its drug for treatment of all...

share

Flex Pharma has initiated a Phase 2 randomized, controlled, double-blinded, parallel design trial in the US. The COMMEND...

share

Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo, Japan-based Eisai Co., Ltd., and Johns Hopkins University announced today...

share

Danish drugmaker Novo Nordisk said on Friday a phase 2 trial for its big hope in tackling obesity, an improved...